openPR Logo
Press release

Polymerase Chain Reaction (PCR) Market Trends Analysis, Share And Growth 2024-2033

10-25-2024 02:00 PM CET | Health & Medicine

Press release from: The Business research company

Polymerase Chain Reaction (PCR) Market Trends

Polymerase Chain Reaction (PCR) Market Trends

The Business Research Company recently released a comprehensive report on the Global Polymerase Chain Reaction (PCR) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The polymerase chain reaction (PCR) market size has grown rapidly in recent years. It will grow from $10.33 billion in 2023 to $11.42 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising number of research facilities, increasing number of patients for chronic and infectious diseases, increasing prevalence of genetic and chronic disorders, increasing population, and growing geriatric population.

The polymerase chain reaction (PCR) market size is expected to see rapid growth in the next few years. It will grow to $17.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the rising concerns over food safety, the increasing demand for safe and high-quality food products, the rising demand for molecular diagnostics, demand for personalized medicine, focus on digital polymerase chain reaction (dPCR). Major trends in the forecast period include real-time polymerase chain reaction, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report

Market Drivers and Trends:

The rising demand for personalized medicine is expected to fuel the growth of the polymerase chain reaction (PCR) market going forward. Personalized medicine, also known as precision medicine, refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in data analytics, patient-specific treatment responses, and the ability to tailor therapies based on individual genetic profiles. Polymerase Chain Reaction (PCR) helps personalized medicine by enabling the amplification and analysis of specific genetic sequences, allowing clinicians to tailor treatment plans based on individual genetic profiles. For instance, according to Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the rising demand for personalized medicine is driving the growth of the polymerase chain reaction market.

Major companies operating in the polymerase chain reaction market are developing real-time polymerase chain reactions test kit to improve accuracy, efficiency, and ease of use in genetic analysis. Real-time polymerase chain reaction (RT-PCR) is a laboratory developed test kit used to amplify and quantify specific DNA sequences in real time. For instance, in November 2022, Cepheid, a US-based molecular diagnostics company, launched Xpert Xpress Multiplex Vaginal Panel (MVP), an FDA-cleared multiplex PCR test that can detect DNA from organisms associated with three distinct vaginal infections - bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis from a single vaginal swab sample.  It enhances the capabilities of traditional polymerase chain reaction methods by providing real-time monitoring, quantification, and increased sensitivity and specificity, making it an indispensable tool in molecular biology and clinical diagnostics. 

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp

Major Key Players of the Market:

F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

Polymerase Chain Reaction (PCR) Market 2024 Key Insights:

• The polymerase chain reaction (PCR) market size is expected to see rapid growth in the next few years. It will grow to $17.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%.
• Impact Of Personalized Medicine On The Polymerase Chain Reaction Market
• Technological Advancements In Polymerase Chain Reaction
• North America was the largest region in the polymerase chain reaction (PCR) market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15638&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polymerase Chain Reaction (PCR) Market Trends Analysis, Share And Growth 2024-2033 here

News-ID: 3710208 • Views:

More Releases from The Business research company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for PCR

Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
The PCR And Realtime PCR Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current PCR And Realtime PCR Testing Market Size and Its Estimated Growth Rate? The PCR and real-time PCR testing market has grown strongly, rising from $10.55 billion in 2024
Global Real Time Pcr Qpcr And Digital Pcr Dpcr Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Real Time Pcr Qpcr And Digital Pcr Dpcr market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The Real-Time PCR (qPCR) and Digital PCR (dPCR) market is experiencing substantial growth, driven by increasing demand for precise
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size? There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size? There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is
Q-PCR and D-PCR Devices Market: Revolutionizing Molecular Diagnostics
The Q-PCR and D-PCR devices market has experienced significant growth in recent years, driven by advancements in molecular biology and the increasing demand for accurate and sensitive diagnostic tools. These technologies have revolutionized the field of molecular diagnostics, enabling researchers and clinicians to detect and quantify specific DNA or RNA sequences with high precision. Market Size and Growth The global Q-PCR and D-PCR devices market is estimated to be worth billions of
Real-Time PCR, Digital PCR And End-Point PCR Global Market Analysis, Trends, Gro …
The new report published by The Business Research Company, titled "Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the real-time pcr, digital pcr and end-point pcr market size has grown strongly